BIWEEKLY DOCETAXEL-CISPLATIN IN CHEMO-NAIVE PATIENTS WITH ADVANCED SQUAMOUS CARCINOMA OF THE LUNG: A GALICIAN LUNG CANCER GROUP PHASE II STUDY

被引：0
|
作者：
Lazaro, Martin [1 ]
Vazquez, S. [2 ]
Jose Villanueva, Maria [3 ]
Firvida, J. L.
Amenedo, Margarita [4 ]
Afonso, Javier
Senin, Clara [3 ]
Campos, Begona
Huidobro, Gerardo [3 ]
Areses, Carmen [5 ]
机构：
[1] Complexo Hosp Univ, La Coruna, Spain
[2] Hosp Univ Lucus Augusti, Lugo, Spain
[3] Complexo Hosp Univ Vigo, Vigo, Spain
[4] Ctr Oncol Galicia, Galicia, Spain
[5] Complexo Hosp Univ Santiago De Compostela, Santiago De Compostela, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
non-squamous; cisplatin; docetaxel;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1278 / S1279
页数：2
相关论文
共 50 条
  • [1] Biweekly Docetaxel-Cisplatin in Chemonaive Patients With Advanced Epidermoid Carcinoma of the Lung - a Phase II Study of Galician Lung Cancer Group
    Lazaro, M.
    Varela, S.
    Vazquez, S.
    Villanueva, M. J.
    Firvida, J. L.
    Amenedo, M.
    Afonso, F. J.
    Senin, C.
    Grande, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S622 - S622
  • [2] A GALICIAN LUNG CANCER GROUP PHASE II STUDY OF BEVACIZUMAB (B), CISPLATIN AND VINORELBINE IN CHEMO-NAIVE PATIENTS (P) WITH NON SQUAMOUS NON SMALL CELL LUNG CANCER (NSCLC)
    Areses Manrique, M. C.
    Vazquez Estevez, S.
    Gracia, J. M.
    Casal Rubio, J.
    Lazaro, M.
    Firvida, J. L.
    Amenedo, M.
    Santome, L.
    Macia, S.
    Leon, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 145 - 145
  • [3] Bevacizumab (B), Cisplatin and Vinorelbine in Chemo-Naive Patients (P) with Non Squamous Non Small Cell Lung Cancer (NSCLC): A Galician Lung Cancer Group Phase II study
    Vazquez, Sergio
    Leon, Luis
    Gracia, Jose M.
    Casal, Joaquin
    Lazaro, Martin
    Luis Firvida, Jose
    Amenedo, Margarita
    Santome, Lucia
    Macia, Sonia
    Alvarez, Elena
    Vicente Cardona, Jose
    Vazquez, Francisca
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S718 - S719
  • [4] Bevacizumab (B), cisplatin and vinorelbine in chemo-naive patients (P) with non squamous non small cell lung cancer (NSCLC): a galician lung cancer group phase II study
    Vazquez, S.
    Leon, L.
    Gracia, J. M.
    Casal, J.
    Lazaro, M.
    Firvida, J. L.
    Amenedo, M.
    Santome, L.
    Cardona, J. V.
    Macia, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 548 - 549
  • [5] Phase II study of nedaplatin, a cisplatin analogue, and docetaxel in patients with advanced squamous cell lung carcinoma
    Naito, Yoichi
    Kubota, Kaoru
    Ohmatsu, Hironobu
    Goto, Koichi
    Niho, Seiji
    Yoh, Kiyotaka
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S452 - S452
  • [6] A phase II study of docetaxel plus irinotecan (DOCIRI) in chemo-naive patients with non small cell lung cancer (NSCLC).
    Ziotopoulos, P
    Chandrinos, V
    Samaras, N
    Mylonaki, E
    Stergiou, J
    Zachariadis, E
    Tsiafaki, X
    Agelidou, A
    Ketepozidis, N
    Georgoulias, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 682S - 682S
  • [7] A phase II randomized trial of vinorelbine plus cisplatin or docetaxel plus cisplatin in inoperable, chemo-naive non-small cell lung cancer patients
    Chen, Y
    Shih, J
    Tsai, C
    Perng, R
    Whang-Peng, J
    LUNG CANCER, 2005, 49 : S389 - S389
  • [8] A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naive non-small-cell lung cancer in Taiwan
    Chen, Yuh-Min
    Perng, Reury-Perng
    Shih, Jen-Fu
    Tsai, Chun-Ming
    Whang-Peng, Jacqueline
    LUNG CANCER, 2007, 56 (03) : 363 - 369
  • [9] Phase II study of nedaplatin and docetaxel in patients with advanced squamous cell carcinoma of the lung
    Naito, Y.
    Kubota, K.
    Ohmatsu, H.
    Goto, K.
    Niho, S.
    Yoh, K.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2011, 22 (11) : 2471 - 2475
  • [10] Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer:: a phase II study of the Galician Lung Cancer Group (GGCP 006-00)
    Vázquez, S
    Grande, C
    Amenedo, M
    Fírvida, JL
    Lázaro, M
    Alonso, G
    Curiel, T
    Huidobro, G
    Mel, JR
    Ramos, M
    ANTI-CANCER DRUGS, 2004, 15 (05) : 489 - 494
12345